However, IRS2 mRNA was reduced in islets from individuals with T2D relative to individuals in the control group (97), suggesting the possibility that a therapeutic intervention that promotes noncanonical CDK4 activity could have relevance in this scenario. This evidence concerns the gene CDK4 and type 2 diabetes mellitus.